A nurse is assessing a 30-year-old client with suspected gastritis who reports chronic use of ibuprofen for arthritis pain.

The client's chronic use of ibuprofen, a non-steroidal anti-inflammatory drug (NSAID), is the critical clue in this scenario. NSAIDs are a well-established cause of gastric mucosal injury, a condition often referred to as NSAID-induced gastropathy. The primary mechanism involves the inhibition of cyclooxygenase-1 (COX-1) enzymes, which are responsible for producing prostaglandins that protect the gastric lining. This protective function includes maintaining mucosal blood flow, stimulating mucus and bicarbonate secretion, and promoting epithelial cell repair. When this defense is compromised, the gastric mucosa becomes vulnerable to injury from gastric acid, leading to inflammation (gastritis), erosions, and potentially ulceration or even perforation [1,3].

The classic clinical presentation of gastritis, whether from NSAIDs or other causes, is epigastric pain or discomfort. This pain is often described as a gnawing or burning sensation. A hallmark feature that helps distinguish it from other gastrointestinal pathologies, such as duodenal ulcer disease, is its relationship to food intake. In gastritis, the pain typically worsens after eating because the presence of food stimulates acid secretion, which further irritates the already inflamed and compromised gastric mucosa. This aligns directly with the correct answer.

• 
  Option 1: Severe, cramping pain in the right lower quadrant. This pain location is characteristic of appendicitis or other pathologies of the terminal ileum and cecum, not the stomach. While NSAIDs can rarely induce injury in the lower gastrointestinal tract, such as the acute colitis described in a recent case report ^[3], the presentation would involve lower abdominal symptoms and potentially hematochezia, not isolated right lower quadrant cramping as a primary sign of gastritis.
  


• 
  Option 2: Clay-colored stools and jaundice. These are classic indicators of a biliary obstruction or hepatocellular disease. Clay-colored stools result from a lack of stercobilin in the feces, and jaundice from elevated serum bilirubin. This symptom complex points to the hepatobiliary system, not the stomach, and is not a direct manifestation of NSAID-induced gastritis.
  


• 
  Option 3: Projectile vomiting and severe headache. Projectile vomiting is a sign of increased intracranial pressure or severe gastric outlet obstruction. While nausea and non-projectile vomiting can occur with severe gastritis or peptic ulcer disease, the combination with a severe headache is a neurological red flag that requires immediate investigation for central nervous system pathology, not a primary gastric issue.
  

This question tests your ability to link a common medication's adverse effect with its most typical clinical presentation. The guidelines for functional dyspepsia, a disorder of gut-brain interaction, emphasize that a careful history of medication use, especially NSAIDs, is a fundamental part of the diagnostic workup for upper gastrointestinal symptoms . While the referenced guideline focuses on functional disorders, the principle of ruling out structural or drug-induced injury is paramount. The rising incidence of NSAID-related gastropathies, including severe complications like bleeding and perforation, underscores the importance of this assessment [1,2]. As a nurse, recognizing that a patient on chronic NSAID therapy reporting epigastric pain worsened by meals is likely suffering from drug-induced gastritis allows for prompt intervention, such as notifying the provider, anticipating the need for a proton pump inhibitor (PPI) or misoprostol, and providing patient education on the risks of long-term NSAID use.